VITL — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-08-06

• During 2026, as a result of economic uncertainty, an industry-wide oversupply of shell eggs and increased price gaps with certain competing shell egg products, we have experienced declining velocities in our shell egg sales to retail customers. This resulted in increased sales to breaker and wholesa…

• During 2026, we made operational staffing changes to reduce headcount and better align our resources with our growth strategies, resulting in a workforce reduction that impacted approximately 12% of our remote crew members.

• In May 2026, we made the strategic decision to wind down our butter business to sharpen our focus on our core egg product categories where we see distinct competitive advantages. We expect to complete the wind down of the butter business by the end of fiscal 2026. In connection with the discontinuat…

• Highly Pathogenic Avian Influenza (“HPAI”) and Other Agricultural Diseases

• Since initial outbreaks of HPAI in early 2022, we have been closely following the progression of the virus and working with our farmers, veterinarians, government health officials and animal welfare auditors to ensure that our flocks are kept as safe as possible. We did not experience an outbreak of…

Text removed vs the prior filing · source: 10-Q · 2026-05-07

• At times during 2026, as a result of economic uncertainty, an industry-wide oversupply of shell eggs and increased price gaps with certain competing shell egg products, we have experienced declining velocities in our shell egg sales. Accordingly, in May 2026, we announced that our growth fell short …

• In May 2026, we also made the strategic decision to wind down our butter business to sharpen our focus on our core egg product categories where we see distinct competitive advantages. We expect to complete the wind down of the butter business by the end of fiscal 2026. In connection with the discont…

• Highly Pathogenic Avian Influenza (HPAI) and Other Agricultural Diseases

• Since initial outbreaks of HPAI in early 2022, we have been closely following the progression of the virus and working with our farmers, veterinarians, government health officials and animal welfare auditors to ensure that our flocks are kept as safe as possible. We did not experience an outbreak of…

• In fiscal 2024, we were made aware of an outbreak of a virus called Egg Drop Syndrome (EDS) in the Midwest. EDS is characterized by the production of pale, thin-shelled, soft-shelled, or shell-less eggs by seemingly healthy laying hens. Twelve of our farms were impacted by EDS in fiscal 2025 and one…

Text added vs the prior filing · source: 10-Q · 2026-08-06

• We may require additional financing to achieve our goals, and the failure to obtain this necessary capital when needed on acceptable terms, or at all, may force us to delay, limit, reduce or terminate our product manufacturing and development, and other operations.

• We may expend significant resources toward the expansion of our processing capacity, which may not provide us with the benefits we expect to receive.

• We have experienced net losses in recent fiscal periods, including a net loss of $1.5 million in the 13-week period ended March 29, 2026 and a net loss of $31.1 million in the 13-week period ended June 28, 2026. During the 13-week period ended June 28, 2026, our gross margin declined significantly, …

• costs or disruptions in our supply chain relating to outbreaks of agricultural diseases, trade wars, tariff regimes, domestic or geopolitical tensions, public health pandemics, inflation or other factors), and we may not succeed in increasing our net revenue and margins sufficiently to offset higher…

• We may require additional financing to achieve our goals, and the failure to obtain this necessary capital when needed on acceptable terms, or at all, may force us to delay, limit, reduce or terminate our product manufacturing and development, and other operations.

Text removed vs the prior filing · source: 10-Q · 2026-05-07

• Our planned Vital Crossroads egg washing and packing facility with onsite cold storage in Indiana, including the impact of our decision to pause construction on Vital Crossroads, or other future expansions of our processing capacity may not provide us with the benefits we expect to receive.

• Our ability to maintain or increase our profitability is subject to various factors, many of which are beyond our control. As we continue to expand our operations, we anticipate that our operating expenses and capital expenditures will continue to increase in the foreseeable future as we invest to i…

• We may require additional financing to achieve our goals, and the failure to obtain this necessary capital when needed on acceptable terms, or at all, may force us to delay, limit, reduce or terminate our product manufacturing and development, and other operations.

• We have funded our operations since inception primarily through equity financings, draws on our credit facilities and sales of

• our products. We have incurred and expect to continue to incur significant expenses related to the expansion of our processing capacity. We believe that we will continue to expend substantial resources for the foreseeable future as we consider additional markets we may choose to pursue and other gro…

Text added vs the prior filing · source: 10-Q · 2026-08-06

• Russell Diez-Canseco, Executive Chairperson, President and Chief Executive Officer

Text removed vs the prior filing · source: 10-Q · 2026-05-07

• Includes up to 2,500 shares subject to vested stock options previously granted to Mr. Wrede. The actual number of shares underlying such stock options that will be sold under the Rule 10b5-1 trading arrangement will be net of the number of shares sufficient to cover the costs associated with the exe…

• Includes up to 12,253 shares subject to vested stock options previously granted to Ms. Bal. The actual number of shares underlying such stock options that will be sold under the Rule 10b5-1 trading arrangement will be net of the number of shares sufficient to cover the costs associated with the exer…